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Drugs used in clinical trials for Covid-19 according to NIH
Amelia Carolina Sparavigna
Politecnico di Torino
Here we show the site ClinicalTrials.gov of NIH and its use to find the drugs involved in clinical
trials for Covid-19. For what concerns the countries where the trials have been proposed, we
considered Italy and France in details. Maps concerning some drugs are also given. In fact, a
georeferentiation of the use of drugs is possible, in order to evidence any possible link between
drugs and the local evolution of pandemic Covid-19.
Torino - 21 May 2020.  DOI: 10.5281/zenodo.3837219
To search for diseases and related experimentations, it is possible to visit the site ClinicalTrials.gov
of  the  National  Institutes  of  Health  (NIH).  It  is  "a  searchable  registry  and results  database  of
federally  and privately  supported  clinical  trials  conducted  in  the  United  States  and  around the
world".  Therefore,  ClinicalTrials.gov  gives  information  about  "a  trial's  purpose,  who  may
participate,  locations,  and phone numbers for more details.  This information should be used in
conjunction with advice from health care professionals". The link is the following:  
 https://www.nih.gov/health-information/nih-clinical-research-trials-you/finding-clinical-trial . 
For instance, let us consider a search for "Covid" and "Italy", on May 20, 2020, we can obtain the
results  which  are  available  according  to  the  following  link:  https://clinicaltrials.gov/ct2/results?
cond=COVID&term=&cntry=IT&state=&city=&dist=
The base information, given in the resulting web-page, concerns Status, Study Title, Conditions,
Interventions  and Locations.  "URL" is  giving a link to a  web-page of NIH containing  detailed
information about the trial. Here, in the following snapshot, an example of a trial using Enoxaparin.
After a general search, we can extract information. For example, we can examine among the clinical
trials,  those  where  specific  drugs  are  reported,  for  being  investigated  and  used  for  Covid-19.
However,  several  other  analyses  of  topics,  about  the  medical  instrumentation  for  instance,  are
possible. There is also the possibility to have a geo-referentiation of drugs; that is, to find a link
between the drug used in a given area where the trial is conducted and the local evolution of the
COVID pandemic.
Here we consider only a specific  example of the use of ClinicalTrials.gov.  As told before,  we
consider the drugs. We give only the trials where a drug is explicitly mentioned in the title or in the
intervention. It is possible that a more detailed analysis of all the records can reveal several other
drugs involved, or that any mistake has been made, in preparing the following lists.  Then, in the
case of a specific interest, a detailed analysis of all reports is suggested. Hyper-immune plasma is
considered in the lists too.  We have investigated Italy and France. Of course,  it would be better to
have an account obtained by means of an analysis on a larger geographical area. However, even
from this small comparison, we can find that differences exist.   
For what concerns investigations on continental  or global scale, ClinicalTrials.gov is displaying
maps, according to the search which has been made. Here we will show some examples of maps
too. Therefore, in the following, we propose two lists concerning trials in Italy and France, with
marked the drugs involved. Then, a few maps concerning some drugs are given. 
Drugs used in Italy 
Comparison of Two Doses of Enoxaparin1 for Thromboprophylaxis in Hospitalized COVID-19 
Patients;  Drug: Enoxaparin    
  URL:                         https://ClinicalTrials.gov/show/NCT04366960
Clinical Study To Evaluate The Performance And Safety Of Favipiravir2 in COVID-19 ;  Drug: 
Favipiravir|Other: Placebo
  URL:                          https://ClinicalTrials.gov/show/NCT04336904
Baricitinib Therapy in COVID-19; Drug: Baricitinib3 4 MG Oral Tablet
  URL:                          https://ClinicalTrials.gov/show/NCT04358614
Use of Ascorbic Acid in Patients With COVID 19;   Dietary Supplement: Vitamin C4
  URL:                          https://ClinicalTrials.gov/show/NCT04323514
ACE Inhibitors, Angiotensin II Type-I Receptor Blockers5 and Severity of COVID-19
  URL:                          https://ClinicalTrials.gov/show/NCT04318418
Hyperimmune Plasma for Critical Patients With COVID-19;   Other: hyperimmune plasma
  URL:                          https://ClinicalTrials.gov/show/NCT04321421
Bacteriotherapy in the Treatment of COVID-19; Dietary Supplement: SivoMixx (200 billion); 
Drug: Azithromycin | Drug: hydroxychloroquine6
   URL:                          https://ClinicalTrials.gov/show/NCT04368351
Efficacy and Safety of Tocilizumab7 in the Treatment of SARS-Cov-2 Related Pneumonia
      URL:                          https://ClinicalTrials.gov/show/NCT04332913
Colchicine in COVID-19: a Pilot Study;  Drug: Colchicine8 1 MG Oral Tablet
    URL:                          https://ClinicalTrials.gov/show/NCT04375202
DAS181 for STOP COVID-19;    Drug: DAS1819 | Drug: Placebo
   URL:                          https://ClinicalTrials.gov/show/NCT04354389
1 https://en.wikipedia.org/wiki/Enoxaparin_sodium
2 https://en.wikipedia.org/wiki/Favipiravir
3 https://en.wikipedia.org/wiki/Baricitinib
4 https://ods.od.nih.gov/factsheets/VitaminC-HealthProfessional/
5 https://www.mayoclinic.org/diseases-conditions/high-blood-pressure/in-depth/ace-inhibitors/art-20047480
6 Sparavigna, Amelia Carolina. (2020, May 17). On the association of Hydroxychloroquine and Azithromycin in 
treating Covid-19 in Italy. Zenodo. http://doi.org/10.5281/zenodo.3831174
7 https://en.wikipedia.org/wiki/Tocilizumab
8 https://en.wikipedia.org/wiki/Colchicine
9 https://biopharmadealmakers.nature.com/users/114908-ansun-biopharma/posts/37800-developing-das181-for-
influenza-and-other-infections ; https://www.clinicaltrialsarena.com/projects/fludase/  ; 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736611/ ; https://journals.plos.org/plosone/article?
id=10.1371/journal.pone.0007838
An Observational Case-control Study of the Use of Siltuximab10 in ARDS Patients Diagnosed With
COVID-19 Infection
    URL:                          https://ClinicalTrials.gov/show/NCT04322188
Baricitinib Compared to Standard Therapy in Patients With COVID-19;   Drug: Baricitinib Oral 
Tablet
  URL:                          https://ClinicalTrials.gov/show/NCT04393051
Renin-Angiotensin System Inhibitors11 and COVID-19
   URL:                          https://ClinicalTrials.gov/show/NCT04331574
Compassionate Use Open-Label Anti-CD14 Treatment in Patients With SARS-CoV-2 (COVID-
19);    Biological: IC14, a monoclonal antibody against CD1412
  URL:                          https://ClinicalTrials.gov/show/NCT04346277
Transfusion of Convalescent Plasma for the Early Treatment of pneumonIa Due to SARSCoV2;   
Biological: CONVALESCENT PLASMA
   URL:                          https://ClinicalTrials.gov/show/NCT04393727
Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation 
of the Gut Microbial Flora;  Other: Oxygen-ozone therapy, probiotic supplementation and Standard
of care | Dietary Supplement: SivoMixx (200 billion) | Drug: Azithromycin | Drug: 
hydroxychloroquine
   URL:                          https://ClinicalTrials.gov/show/NCT04366089
The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients; Drug: Sitagliptin13
   URL:                          https://ClinicalTrials.gov/show/NCT04365517
Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus 
Disease (COVID-19);  Drug: Hydroxychloroquine
  URL:                          https://ClinicalTrials.gov/show/NCT04363827
TOFAcitinib in SARS-CoV2 Pneumonia;  Drug: Tofacitinib14
  URL:                          https://ClinicalTrials.gov/show/NCT04332042
Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease 
Progression;  Biological: COVID-19 Convalescent Plasma
   URL:                          https://ClinicalTrials.gov/show/NCT04374526
Colchicine Counteracting Inflammation in COVID-19 Pneumonia;   Drug: Colchicine
  URL:                          https://ClinicalTrials.gov/show/NCT04322565
Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin15 in Patients Affected 
by COVID-19; Drug: Oxytocin|Drug: Standard of Care
  URL:                          https://ClinicalTrials.gov/show/NCT04386447
Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study; Drug: 
Baricitinib
10 https://en.wikipedia.org/wiki/Siltuximab
11 https://www.nejm.org/doi/full/10.1056/NEJMsr2005760 ; 
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31030-8/fulltext
12 https://pubmed.ncbi.nlm.nih.gov/11717588/ ; https://pubmed.ncbi.nlm.nih.gov/11207321/
13 https://en.wikipedia.org/wiki/Sitagliptin
14 https://en.wikipedia.org/wiki/Tofacitinib
15 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177061/
   URL:                          https://ClinicalTrials.gov/show/NCT04320277
Efficacy of Methylprednisolone16 for Patients With COVID-19 Severe Acute Respiratory 
Syndrome;  Drug: Methylprednisolone|Other: standard care
  URL:                          https://ClinicalTrials.gov/show/NCT04323592
Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19; Drug: Tirofiban17 Injection|
Drug: Clopidogrel18 | Drug: Acetylsalicylic acid19 | Drug: Fondaparinux20
  URL:                          https://ClinicalTrials.gov/show/NCT04368377
Escin in Patients With Covid-19 Infection;  Drug: Escin21 | Drug: standard therapy
   URL:                          https://ClinicalTrials.gov/show/NCT04322344
Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis; Drug: Tocilizumab
  URL:                          https://ClinicalTrials.gov/show/NCT04315480
Efficacy and Safety of Emapalumab and Anakinra22 in Reducing Hyperinflammation and 
Respiratory Distress in Patients With COVID-19 Infection; Biological: Emapalumab|Biological: 
Anakinra
  URL:                          https://ClinicalTrials.gov/show/NCT04324021
Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia; Drug: Bevacizumab23 
Injection
  URL:                          https://ClinicalTrials.gov/show/NCT04275414
Sitagliptin Treatment in Diabetic COVID-19 Positive Patients; Drug: Retrospective case-control 
analysis
  URL:                          https://ClinicalTrials.gov/show/NCT04382794
Hyperimmune Plasma in Patients With COVID-19 Severe Infection;  Other: plasma 
hyperimmune|Drug: standard therapy
  URL:                          https://ClinicalTrials.gov/show/NCT04385043
Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients; Biological: Anti-
coronavirus antibodies (immunoglobulins)obtained with DFPP from convalescent patients
 URL:                          https://ClinicalTrials.gov/show/NCT04346589
Tocilizumab in COVID-19 Pneumonia (TOCIVID-19); Drug: Tocilizumab Injection
  URL:                          https://ClinicalTrials.gov/show/NCT04317092
Acalabrutinib24 Study With Best Supportive Care Versus Best Supportive Care in Subjects 
Hospitalized With COVID-19; Drug: Acalabrutinib
  URL:                          https://ClinicalTrials.gov/show/NCT04346199
Efficacy of Early Administration of Tocilizumab in COVID-19 Patients; Drug: Tocilizumab
  URL:                          https://ClinicalTrials.gov/show/NCT04346355
16 https://www.healthline.com/health/methylprednisolone-oral-tablet
17 https://en.wikipedia.org/wiki/Tirofiban
18 https://en.wikipedia.org/wiki/Clopidogrel
19 https://en.wikipedia.org/wiki/Aspirin
20 https://www.uptodate.com/contents/fondaparinux-dosing-and-adverse-effects
21 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776292/ ; 
https://www.sciencedirect.com/topics/neuroscience/escin
22 https://salute.regione.emilia-romagna.it/farmaci/covid-19/farmaci-e-studi-clinici/anakinra-emapalumab
23 https://en.wikipedia.org/wiki/Bevacizumab
24 https://en.wikipedia.org/wiki/Acalabrutinib
Study to Evaluate the Safety and Antiviral Activity of Remdesivir25 (GS-.5734TM) in Participants 
With Severe Coronavirus Disease (COVID-19);  Drug: Remdesivir|Drug: Standard of Care
  URL:                          https://ClinicalTrials.gov/show/NCT04292899
Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734TM) in Participants 
With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment;    
Drug: Remdesivir|Drug: Standard of Care
    URL:                          https://ClinicalTrials.gov/show/NCT04292730
A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 
Pneumonia;   Drug: Tocilizumab (TCZ)|Drug: Placebo
  URL:                          https://ClinicalTrials.gov/show/NCT04320615
 Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-
CoV2 (CoV) Infection (COVID-19); Drug: Remdesivir
   URL:                          https://ClinicalTrials.gov/show/NCT04323761
  Sarilumab COVID-19; Drug: Sarilumab26 SAR153191|Drug: Placebo
    URL:                          https://ClinicalTrials.gov/show/NCT04327388
Drugs used in France
Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19;  Drug: 1: 
ILT10127 | Drug: 2: Placebo Comparator
  URL:                          https://ClinicalTrials.gov/show/NCT04357444
Hydroxychloroquine Azithromycin COVID-19 Pregnancy Trial;    Drug: Hydroxychloroquine 
and azithromycin treatment | Other: conventional management of patients
   URL:                          https://ClinicalTrials.gov/show/NCT04365231
Avdoralimab28 an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia 
( FORCE );   Biological: avdoralimab|Other: Placebo 
  URL:                          https://ClinicalTrials.gov/show/NCT04371367
Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients;           
Drug: Hydroxychloroquine | Drug: Azithromycin
   URL:                          https://ClinicalTrials.gov/show/NCT04341207
 Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the 
CORIMUNO-19 Cohort; Drug: Transfusion of COVID-19 convalescent plasma
    URL:                          https://ClinicalTrials.gov/show/NCT04345991
Repurposing of Chlorpromazine29 in Covid-19 Treatment; Drug: CHLORPROMAZINE (CPZ)|
Combination Product: Standard of Care (SOC)
    URL:                          https://ClinicalTrials.gov/show/NCT04366739
Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19
Infections;  Drug: Remdesivir
25 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31022-9/fulltext
26 https://en.wikipedia.org/wiki/Sarilumab
27 https://lupusnewstoday.com/2017/06/01/servier-iltoo-pharma-agree-to-develop-commercialize-ilt-101-as-lupus-
treatment/
28 https://fr.wikipedia.org/wiki/Avdoralimab
29 https://www.drugs.com/mtm/chlorpromazine.html
    URL:                          https://ClinicalTrials.gov/show/NCT04365725
ABX46430 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With 
COVID-19;  Drug: ABX464|Drug: Placebo
    URL:                          https://ClinicalTrials.gov/show/NCT04393038
Trial Evaluating Efficacy and Safety of Nivolumab31 (Optivo®) in Patients With COVID-19 
Infection, Nested in the Corimmuno-19 Cohort;  Drug: Nivolumab Injection
    URL:                          https://ClinicalTrials.gov/show/NCT04343144
Randomised, Double-blind, Placebo-controlled Phase 2 Study Evaluating the Efficacy of 
Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological 
Malignancies; Drug: Hydroxychloroquine Sulfate 200 MG [Plaquenil] | Drug: Azithromycin 250 
MG Oral Capsule|Drug: Placebo oral tablet|Drug: Placebo oral capsule
    URL:                          https://ClinicalTrials.gov/show/NCT04392128
Efficacy of Hydroxychloroquine, Telmisartan32 and Azithromycin on the Survival of 
Hospitalized Elderly Patients With COVID-19; Drug: Hydroxychloroquine|Drug: Azithromycin|
Drug: Telmisartan
    URL:                          https://ClinicalTrials.gov/show/NCT04359953
Povidone Iodine33 Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in
Patients With COVID-19;  Drug: Povidone-Iodine
   URL:                          https://ClinicalTrials.gov/show/NCT04371965
Drug Management of Rheumatoid Arthritis in Covid-19 Context : Impact on Therapeutic De-
escalation  [patients are assuming drugs for sure, therefore this study is very important]     
   URL:                          https://ClinicalTrials.gov/show/NCT04393233
Efficacy and Safety of Aerosolized Intra-tracheal Dornase Alpha Administration in Patients With 
COVID19-induced ARDS (COVIDORNASE);  Drug: Dornase Alfa34 Inhalation Solution 
[Pulmozyme]|Procedure: standard procedure
   URL:                          https://ClinicalTrials.gov/show/NCT04355364
Proactive Care of Ambulatory COVID19 Patients;    Other: consultation|Drug: Azithromycin
    URL:                          https://ClinicalTrials.gov/show/NCT04371107
Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia;    
Drug: Dexamethasone35 injection|Drug: placebo|Procedure: conventional oxygen|Procedure: CPAP|
Procedure: HFNO|Procedure: mechanical ventilation
    URL:                          https://ClinicalTrials.gov/show/NCT04344730
Almitrine36 and COVID-19 Related Hypoxemia             
  URL:                          https://ClinicalTrials.gov/show/NCT04380727
Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients 
With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia; Drug: Almitrine|
Drug: Placebo
30 https://www.nature.com/articles/s41598-018-37813-y
31 https://en.wikipedia.org/wiki/Nivolumab
32 http://www.informazionisuifarmaci.it/telmisartan
33 https://en.wikipedia.org/wiki/Povidone-iodine
34 https://www.cochrane.org/CD001127/CF_dornase-alfa-inhaled-drug-treating-lung-disease-cystic-fibrosis
35 https://en.wikipedia.org/wiki/Dexamethasone
36 https://en.wikipedia.org/wiki/Almitrine
    URL:                          https://ClinicalTrials.gov/show/NCT04357457
Long-term Use of Drugs That Could Prevent the Risk of Serious COVID-19 Infections or Make it 
Worse;    Other: - Synthetic anti-malarial drugs
    URL:                          https://ClinicalTrials.gov/show/NCT04356417
Protective Role of Inhaled Steroids for Covid-19 Infection; Drug: 2: Usual practice + 
SYMBICORT RAPIHALER37 | Other: 1: Usual practice
    URL:                          https://ClinicalTrials.gov/show/NCT04331054
Covid-19 in Lupus Patients  Interventions:  [in the Search Result, no intervention is detailed; 
however, it is sure that Lupus patients are assuming drugs, therefore this study is very important]     
   URL:                          https://ClinicalTrials.gov/show/NCT04355702
Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-
19; Drug: Dexamethasone38 and Hydroxychloroquine | Drug: Hydroxychloroquine
    URL:                          https://ClinicalTrials.gov/show/NCT04347980
Use of a Respiratory Multiplex PCR and Procalcitonin39 to Reduce Antibiotics Exposure in 
Patients With Severe Confirmed COVID-19 Pneumonia; Procedure: Combined use of a respiratory 
broad panel multiplex PCR and procalcitonin|Other: Usual antibiotic treatment
    URL:                          https://ClinicalTrials.gov/show/NCT04334850
Polyvalent Immunoglobulin in COVID-19 Related ARds; Drug: Human immunoglobulin40 | 
Drug: Placebo
    URL:                          https://ClinicalTrials.gov/show/NCT04350580
A Study of Trans Crocetin in Patients With Acute Respiratory Distress Syndrome Due to COVID-
19 Disease (LEAF-4L7520/4L6715); Drug: LEAF-4L671541 | Drug: LEAF-4L7520
   URL:                          https://ClinicalTrials.gov/show/NCT04378920
Treatments to Decrease the Risk of Hospitalization or Death in Elderly Outpatients With 
Symptomatic SARS-CoV-2 Infection (COVID-19); Dietary Supplement: Vitamins | Drug: 
Hydroxychloroquine | Drug: Imatinib42 | Drug: Favipiravir | Drug: Telmisartan
    URL:                          https://ClinicalTrials.gov/show/NCT04356495
Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of 
a Sars-cov-2 / COVID-19 Infection; Drug: Treatment with Dexmedetomidine43
    URL:                          https://ClinicalTrials.gov/show/NCT04350086
Anakinra for COVID-19 Respiratory Symptoms; Drug: Anakinra44 plus oSOC|Drug: oSOC
    URL:                          https://ClinicalTrials.gov/show/NCT04364009
Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-
inflammatory Rare and Non-rare Diseases;  Interventions:    [in the Search Result, no intervention is
detailed; however, it is sure that these patients are assuming drugs, therefore this study is very 
important]             
37 https://www.nps.org.au/medicine-finder/symbicort-rapihaler-50-3-metered-dose-inhaler
38 https://en.wikipedia.org/wiki/Dexamethasone
39 https://en.wikipedia.org/wiki/Procalcitonin
40 https://en.wikipedia.org/wiki/Immunoglobulin_therapy
41   No info available on LEAF-4L7520/4L6715 ; https://www.medchemexpress.com/Transcrocetin.html
42 https://en.wikipedia.org/wiki/Imatinib
43 https://en.wikipedia.org/wiki/Dexmedetomidine
44 https://en.wikipedia.org/wiki/Anakinra
    URL:                          https://ClinicalTrials.gov/show/NCT04353609
Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, 
Nested in the Corimmuno-19 Cohort; Drug: Tinzaparin45 or unfractionated heparin46
    URL:                          https://ClinicalTrials.gov/show/NCT04344756
ACE Inhibitors or ARBs Discontinuation in Context of SARS-CoV-2 Pandemic; Drug: 1: 
discontinuation of RAS blocker therapy | Drug: 2: continuation of RAS blocker47 therapy
    URL:                          https://ClinicalTrials.gov/show/NCT04329195
Efficacy of Intravenous Anakinra and Ruxolitinib48 During COVID-19 Inflammation 
(JAKINCOV); Drug: Anakinra alone (stages 2b/3)|Drug: Anakinra and Ruxolitinib (overcome stage
3)|Other: Standard of care
    URL:                          https://ClinicalTrials.gov/show/NCT04366232
CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab49 (Soliris) in Patients 
With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort; Drug: Eculizumab
   URL:                          https://ClinicalTrials.gov/show/NCT04346797
Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With 
Pneumonia in Non-intensive Unit; Combination Product: Azithromycin50 with 
amoxicillin/clavulanate|Drug: amoxicillin/clavulanate51
   URL:                          https://ClinicalTrials.gov/show/NCT04363060
Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related 
ARDS;  Biological: Umbilical cord Wharton's jelly-derived human52 | Other: NaCl 0.9%
    URL:                          https://ClinicalTrials.gov/show/NCT04333368
Efficacy of BCG Vaccination53 in the Prevention of COVID19 Via the Strengthening of Innate 
Immunity in Health Care Workers; Biological: BCG GROUP | Other: PLACEBO GROUP
    URL:                          https://ClinicalTrials.gov/show/NCT04384549
Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 
Pneumonia (COVIDOC Trial); Drug: Hydroxychloroquine + placebo|Drug: hydroxychloroquine + 
azithromycin
    URL:                          https://ClinicalTrials.gov/show/NCT04345861
Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients;  Drug: 
Transfusion of SARS-CoV-2 Convalescent Plasma.|Drug: Transfusion of standard Plasma.
    URL:                          https://ClinicalTrials.gov/show/NCT04372979
IMATINIB IN COVID-19 DISEASE IN AGED PATIENTS;  Drug: Experimental drug
    URL:                          https://ClinicalTrials.gov/show/NCT04357613
Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by
COVID-19; Drug: Oxytocin|Drug: Standard of Care
45 https://www.rxlist.com/innohep-drug.htm
46 https://en.wikipedia.org/wiki/Heparin
47 https://www.ema.europa.eu/en/medicines/human/referrals/renin-angiotensin-system-ras-acting-agents
48 https://www.osservatoriomalattierare.it/news/attualita/15942-covid-19-ruxolitinib-entra-nel-programma-di-uso-
compassionevole
49 https://en.wikipedia.org/wiki/Eculizumab
50 https://en.wikipedia.org/wiki/Azithromycin
51 https://www.rxlist.com/augmentin-drug.htm
52 https://en.wikipedia.org/wiki/Wharton%27s_jelly
53 https://en.wikipedia.org/wiki/BCG_vaccine
    URL:                          https://ClinicalTrials.gov/show/NCT04386447
OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome;  Drug: 
Azithromycin | Drug: Hydroxychloroquine | Drug: Lopinavir 200Mg/ Ritonavir54 50Mg Tab
  URL:                          https://ClinicalTrials.gov/show/NCT04365582
 Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, 
Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO; Drug: Sarilumab | Drug: 
Azithromycin|Drug: Hydroxychloroquine
   URL:                          https://ClinicalTrials.gov/show/NCT04341870
SOLIRIS® (Eculizumab) Treatment of Participants With COVID-19;  Biological: eculizumab
    URL:                          https://ClinicalTrials.gov/show/NCT04355494
DYNAMIC Study (DoxycYcliNe AMbulatoIre COVID-19);   Drug: Doxycycline55 | Drug: Placebo
   URL:                          https://ClinicalTrials.gov/show/NCT04371952
Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other
Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI; Drug: Sarilumab
   URL:                          https://ClinicalTrials.gov/show/NCT04324073
Impact of Long-term Protease Inhibitors56 in Patients Living With HIV on the Incidence of 
COVID-19 ( COVIP ); Other: No intervention
    URL:                          https://ClinicalTrials.gov/show/NCT04357639
Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers; Drug: 
Hydroxychloroquine | Drug: Placebo of Hydroxychloroquine|Drug: Lopinavir and ritonavir | 
Drug: Placebo of LPV/r Tablets
    URL:                          https://ClinicalTrials.gov/show/NCT04328285
Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection;   Drug: 
Prednisone57 | Other: Control group
   URL:                          https://ClinicalTrials.gov/show/NCT04344288
Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants 
With Severe Coronavirus Disease (COVID-19);    Drug: Remdesivir|Drug: Standard of Care
    URL:                          https://ClinicalTrials.gov/show/NCT04292899
Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants 
With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment; Drug: 
Remdesivir|Drug: Standard of Care
    URL:                          https://ClinicalTrials.gov/show/NCT04292730
A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 
Pneumonia;   Drug: Tocilizumab (TCZ)|Drug: Placebo
   URL:                          https://ClinicalTrials.gov/show/NCT04320615
Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects 
Hospitalized With COVID-19;  Drug: Acalabrutinib
   URL:                          https://ClinicalTrials.gov/show/NCT04346199
54 https://www.humanitas.it/enciclopedia/principi-attivi/antivirali/combinazione-lopinavir-ritonavir ; 
https://it.wikipedia.org/wiki/Lopinavir/ritonavir
55 https://www.drugs.com/doxycycline.html
56 https://en.wikipedia.org/wiki/Protease_inhibitor_(pharmacology)
57 https://it.wikipedia.org/wiki/Prednisone
Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection;   
Drug: Chloroquine analog (GNS651)58 | Drug: Nivolumab |Drug: Tocilizumab | Other: Standard 
of care
  URL:                          https://ClinicalTrials.gov/show/NCT04333914
Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus;  Drug: 
hydroxychloroquine | Drug: azithromycin | Drug: hydroxychloroquine placebo
  URL:                          https://ClinicalTrials.gov/show/NCT04344379
Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous 
Thromboembolism Prevention in COVID-19;    Drug: Enoxaparin
  URL:                          https://ClinicalTrials.gov/show/NCT04373707
Efficacy of Captopril59 in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) 
CoV-2 Pneumonia (CAPTOCOVID);   Drug: captopril 25mg
   URL:                          https://ClinicalTrials.gov/show/NCT04355429
Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-
CoV2 (CoV) Infection (COVID-19);  Drug: Remdesivir
    URL:                          https://ClinicalTrials.gov/show/NCT04323761
Trial of Treatments for COVID-19 in Hospitalized Adults; Drug: Remdesivir | Drug: 
Lopinavir/ritonavir | Drug: Interferon Beta-1A60 | Drug: Hydroxychloroquine | Other: Standard 
of care
    URL:                          https://ClinicalTrials.gov/show/NCT04315948
Sarilumab COVID-19;    Drug: Sarilumab SAR153191|Drug: Placebo
    URL:                          https://ClinicalTrials.gov/show/NCT04327388
Evaluation of Activity and Safety of Oral Selinexor61 in Participants With Severe COVID-19 
Infection; Drug: Selinexor|Other: Placebo
    URL:                          https://ClinicalTrials.gov/show/NCT04349098
 COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High 
Dose Versus Standard Dose Vitamin D362 in High-risk COVID-19 Patients (CoVitTrial);     Drug: 
cholecalciferol 200,000 IU|Drug: cholecalciferol 50,000 IU
  URL:                          https://ClinicalTrials.gov/show/NCT04344041
Hydroxychloroquine in Outpatient Adults With COVID-19;  Drug: Hydroxychloroquine 
SAR321068|Drug: Placebo
  URL:                          https://ClinicalTrials.gov/show/NCT04333654
  Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease; Drug: 
Hydroxychloroquine|Drug: Placebo
  URL:                          https://ClinicalTrials.gov/show/NCT04325893
Role of Ibuprofen63 and Other Medicines on Severity of Coronavirus Disease 2019;   Other: 
Questionnaire
58 https://www.genosciencepharma.com/2020/04/05/important-advances-in-novel-covid-19-antiviral-program/
59 https://it.wikipedia.org/wiki/Captopril
60 https://en.wikipedia.org/wiki/Interferon_beta-1a
61 https://en.wikipedia.org/wiki/Selinexor
62 Sparavigna, Amelia Carolina. (2020, May 12). Vitamin D for Covid-19?. Zenodo.  
http://doi.org/10.5281/zenodo.3822187
63 https://en.wikipedia.org/wiki/Ibuprofen
    URL:                          https://ClinicalTrials.gov/show/NCT04383899
CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI);    Drug: Tocilizumab
  URL:                          https://ClinicalTrials.gov/show/NCT04331808
From the lists given above, we can see that some drugs are largely involved in trials, so it could be 
useful to observe the related maps of them, on global and continental (Europe) scale.
Maps (Courtesy ClinicalTrials.gov)
Maps of the clinical trials using Hydroxychloroquine
 Maps of the clinical trials using  Azithromycin
-----------------------------------------------------
Maps of the clinical trials using the association of Hydroxychloroquine and Azithromycin
Maps of the clinical trials using Tocilizumab
-----------------------------------------------
 Maps of the clinical trials using  Remdesivir
